Category: New products
-
Researchers Develop Eye Injury Test, Start Company
9 December 2015. A medical and engineering team at University of Illinois in Champaign designed a sensor providing a quick, portable test for the severity of eye injuries. The researchers led by bioengineering professor Dipanjan Pan and ophthalmologist Leanne Labriola at Carle Foundation Hospital affiliated with the university described the proof-of-concept device last month in the…
-
University Spin-Off Develops Pain Killer Patch
8 December 2015. A new company begun by a chemistry professor in the U.K. is developing a patch infused with ibuprofen for people needing relief from pain or inflammation from arthritis. Medherant Ltd., in Coventry, is developing the patch based on research at University of Warwick conducted by David Haddleton, who founded the company and…
-
Trial Underway Testing Flesh-Eating Bacteria Drug
7 December 2015. A late-stage clinical trial began enrolling patients to test a new treatment for rare, but dangerous bacterial infections that destroy soft tissue and muscle. The trial is testing AB103, a biologic therapy developed by the biotechnology company Atox Bio in Ness Ziona, Israel. AB103 is designed to treat necrotizing soft tissue infections,…
-
Antibodies Reduce Whooping Cough Severity, Infections
3 December 2015. Two engineered antibodies were shown in tests with lab animals to reduce the severity of whooping cough symptoms and white blood cell counts indicating infection. The team from the protein engineering lab of Jennifer Maynard at University of Texas in Austin and Synthetic Biologics, a biotechnology company in Rockville, Maryland, published its…
-
Chlamydia Vaccine Shown Working in Lab Tests
2 December 2015. An experimental vaccine to prevent chlamydia was shown in tests with lab mice to prevent pelvic inflammation and clear bacteria more than mice not receiving the vaccine. The vaccine, given through the nose, is made by NanoBio Corp., a biopharmaceutical company in Ann Arbor, Michigan. Chlamydia is a sexually transmitted disease that…
-
Wearable Personal Instruction System Being Developed
2 December 2015. A device that provides personal step-by-step instruction to individuals as they undertake various tasks is being developed by computer scientists at Carnegie Mellon University. The system, designed in the lab of professor Mahadev Satyanarayanan, is funded by a four-year $2.8 million grant from National Science Foundation. Satyanarayanan and colleagues are seeking a…
-
CRISPR-Cas9 Gene Editing Made More Accurate
1 December 2015. Medical and engineering researchers enhanced emerging CRISPR-Cas9 genome editing techniques, reducing erroneous off-target edits with an engineered enzyme. The team from the Broad Institute, a medical research center at Harvard University and Massachusetts Institute of Technology, and the McGovern Institute for Brain Research at MIT, published its findings today online in Science…
-
Implanted Sensor to Measure Blood Sugar in Development
1 December 2015. An engineering group at University of Texas in Arlington is developing a system for people with diabetes to measure their blood glucose levels without taking repeated blood drops throughout the day. The work in the lab of biomaterials professor Kyungsuk Yum is funded by a $100,00 grant from the Texas Medical Research Collaborative.…
-
Crop Disease Images Collected, Available Via Smartphones
25 November 2015. A team in the U.S. and Switzerland is assembling a database of 50,000 images of plant diseases for a smartphone app to help farmers worldwide deal with those diseases. Entomologist David Hughes at Pennsylvania State University in University Park and epidemiologist Marcel Salathé at Ecole polytechnique fédérale de Lausanne or EPFL, the…
-
Antibodies to Treat Staph Infections in Early Trial
24 November 2015. A study testing the safety of antibodies to prevent and treat Staphylococcus aureus infections, including those contracted in hospitals, is underway in Vienna, Austria. The clinical trial is evaluating an experimental biologic drug for the prevention and treatment of S. aureus or staph infections made by Arsanis Biosciences, a biotechnology company in…